She underwent Tru-cut biopsy with a diagnosis of invasive ductal breast carcinoma (95% of tumor cells expressed estrogen receptor (ER), 40% progesterone receptor (PgR), 40% Ki67 and were HER2 negative). This evidence concerns the gene PGR and invasive ductal breast carcinoma.